ALMOOSA

Almoosa Health Co.

4018StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	Q1 2026Mar 31, 2026	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025
Market & Price
Market Capitalization	5.17B	6.12B	7.77B	7.45B	7.19B
Market Cap Growth	-32.9%	-8.0%	—	—	—
Enterprise Value	6.14B	6.91B	8.38B	7.90B	7.41B
Last Close Price	116.70	137.91	174.57	167.00	160.82
Valuation Multiples
Forward PE (Next 12M Est.)	23.06	19.67	27.28	27.69	33.68
PE Ratio	26.81	29.31	30.76	41.47	46.10
PEG Ratio	0.60	0.50	0.70	0.71	1.11
PS Ratio	3.59	4.25	5.49	5.47	5.48
PB Ratio	2.67	3.17	4.04	3.83	3.77
P/TBV Ratio	2.69	3.19	4.06	3.85	3.78
P/FCF Ratio	—	—	-27.34	—	—
P/OCF Ratio	26.85	39.95	54.91	98.10	—
EV/Sales Ratio	4.26	4.80	5.92	5.81	5.65
EV/EBITDA Ratio	19.89	23.14	27.36	24.87	23.92
EV/EBIT Ratio	29.40	32.99	37.93	33.42	32.12
EV/FCF Ratio	—	—	-29.49	—	—
Leverage & Capital
Debt / Equity Ratio	0.54	0.54	0.45	0.39	0.32
Debt / EBITDA Ratio	3.38	3.85	2.61	2.32	1.98
Debt / FCF Ratio	—	—	-3.06	—	—
Net Debt / Equity Ratio	0.50	0.50	0.41	0.32	0.24
Net Debt / EBITDA Ratio	3.25	3.24	2.58	1.93	1.46
Net Debt / FCF Ratio	-2.55	-2.55	-2.78	-1.91	-1.73
Efficiency & Liquidity
Asset Turnover	0.40	0.48	0.46	0.46	0.47
Inventory Turnover	12.93	12.44	15.32	12.55	12.48
Quick Ratio	1.47	1.47	1.50	1.71	1.86
Current Ratio	1.71	1.71	1.72	1.96	2.11
Returns & Yields
Return on Equity (ROE)	+4.9%	+17.0%	+10.7%	+10.8%	+21.2%
Return on Assets (ROA)	+2.9%	+4.5%	+4.6%	+4.5%	+4.6%
Return on Invested Capital (ROIC)	+1.4%	+2.1%	+2.3%	+2.4%	+2.5%
Return on Capital Employed (ROCE)	+6.8%	+6.8%	+7.8%	+8.5%	+8.8%
Earnings Yield	+3.7%	+3.4%	+3.3%	+2.4%	+2.2%
FCF Yield	-7.3%	-6.2%	-3.7%	-4.3%	-3.6%
Dividend Yield	+1.2%	+0.9%	+0.7%	+1.2%	+1.0%
Payout Ratio	+44.8%	—	+18.9%	+30.0%	+107.0%
Buyback Yield / Dilution	-19.2%	-1.4%	-26.6%	-29.6%	-40.5%
Total Shareholder Return	-18.0%	-0.5%	-25.8%	-28.4%	-39.5%

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	Q1 2026Mar 31, 2026	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025
Market & Price
Market Capitalization	5.17B	6.12B	7.77B	7.45B	7.19B
Market Cap Growth	-32.9%	-8.0%	—	—	—
Enterprise Value	6.14B	6.91B	8.38B	7.90B	7.41B
Last Close Price	116.70	137.91	174.57	167.00	160.82
Valuation Multiples
Forward PE (Next 12M Est.)	23.06	19.67	27.28	27.69	33.68
PE Ratio	26.81	29.31	30.76	41.47	46.10
PEG Ratio	0.60	0.50	0.70	0.71	1.11
PS Ratio	3.59	4.25	5.49	5.47	5.48
PB Ratio	2.67	3.17	4.04	3.83	3.77
P/TBV Ratio	2.69	3.19	4.06	3.85	3.78
P/FCF Ratio	—	—	-27.34	—	—
P/OCF Ratio	26.85	39.95	54.91	98.10	—
EV/Sales Ratio	4.26	4.80	5.92	5.81	5.65
EV/EBITDA Ratio	19.89	23.14	27.36	24.87	23.92
EV/EBIT Ratio	29.40	32.99	37.93	33.42	32.12
EV/FCF Ratio	—	—	-29.49	—	—
Leverage & Capital
Debt / Equity Ratio	0.54	0.54	0.45	0.39	0.32
Debt / EBITDA Ratio	3.38	3.85	2.61	2.32	1.98
Debt / FCF Ratio	—	—	-3.06	—	—
Net Debt / Equity Ratio	0.50	0.50	0.41	0.32	0.24
Net Debt / EBITDA Ratio	3.25	3.24	2.58	1.93	1.46
Net Debt / FCF Ratio	-2.55	-2.55	-2.78	-1.91	-1.73
Efficiency & Liquidity
Asset Turnover	0.40	0.48	0.46	0.46	0.47
Inventory Turnover	12.93	12.44	15.32	12.55	12.48
Quick Ratio	1.47	1.47	1.50	1.71	1.86
Current Ratio	1.71	1.71	1.72	1.96	2.11
Returns & Yields
Return on Equity (ROE)	+4.9%	+17.0%	+10.7%	+10.8%	+21.2%
Return on Assets (ROA)	+2.9%	+4.5%	+4.6%	+4.5%	+4.6%
Return on Invested Capital (ROIC)	+1.4%	+2.1%	+2.3%	+2.4%	+2.5%
Return on Capital Employed (ROCE)	+6.8%	+6.8%	+7.8%	+8.5%	+8.8%
Earnings Yield	+3.7%	+3.4%	+3.3%	+2.4%	+2.2%
FCF Yield	-7.3%	-6.2%	-3.7%	-4.3%	-3.6%
Dividend Yield	+1.2%	+0.9%	+0.7%	+1.2%	+1.0%
Payout Ratio	+44.8%	—	+18.9%	+30.0%	+107.0%
Buyback Yield / Dilution	-19.2%	-1.4%	-26.6%	-29.6%	-40.5%
Total Shareholder Return	-18.0%	-0.5%	-25.8%	-28.4%	-39.5%